Octavus Consulting- Evidence-Based Consulting Services.

Call us: +91 120 428 0707

Recruitment Mapping & Clinical Trial Analysis

Case Details

Start Day: 05/06/2024

Clients: Mid-to-large Biopharma Company

Tags: Clinical Trial Recruitment, Recruitment Analysis, NSCLC Trials, Neuroendocrine Tumor Trials, Net Clinical Trials, Moa Analysis, Phase Ii Clinical Trials, EU Clinical Research, Recruitment Hotspots Europe, Clinical Trial Mapping, Clinical Trial Timelines, Oncology Clinical Trials, Trial Site Selection, Patient Recruitment Strategy, Biopharma Insights, Clinical Operations Europe, Trial Design Optimization, Oncology Research Europe, Competitive Recruitment Analysis, Clinical Development Strategy

Project Duration: 04 Months

Let’s Work Together for Development

Call us directly, submit a sample or email us!

Business Address
First Floor, B-66, Sector 63,
Noida, UP, India-201301
Connect With Us
Call us: +91 120 428 0707
bd@octavusconsulting.com
Working Hours
Mon - Fri: 10.00 AM - 07.00 PM
Holidays : Closed

The Story

Recruitment Mapping and Analysis of Clinical Trials

Conducted clinical trial and recruitment analysis for Phase II and above MOAs in NSCLC and NET across the EU, which helped client in selecting optimal trial locations and timelines to enhance recruitment efficiency and trial success.

What Did Octavus Do

We conducted clinical trial summarization and recruitment analysis of targeted MOA in NSCLC and NET across the EU.

This helped the client design clinical trials and choose locations across the EU with less recruitment competition and avoid slower recruitment in trials.

Data Analysis Chart

Recruitment Mapping & Clinical Trial Analysis

The Results

Octavus proposed these solutions based on the research conducted for Client.

Screening and identification of drugs developed in the EU for NSCLC and NET in the targeted MOAs
Providing an overview of recruitment analysis and summarization, and creation of timeline for all clinical trials and late-phase trials in specific categories
Recruitment analysis of all trials for each MOA and identified recruitment hotspots across the EU